Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula

Systematic and Applied Microbiology

Volumn 36, Issue 3, 2013, Pages 188-196

  Yin, Xiaochen ^a   Peng, Jinghua ^b   Zhao, Liping ^a,c   Yu, Yunpeng ^a   Zhang, Xu ^a   Liu, Ping ^d   Feng, Qin ^b   Hu, Yiyang ^b,d   Pang, Xiaoyan ^a  

^a Shanghai Jiao Tong University   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^d Shanghai Municipal Education Commission   (China)

Author keywords

Chinese herbal formula; Gut microbiota; Non alcoholic fatty liver disease (NAFLD); Polymerase chain reaction denaturing gradient gel electrophoresis (PCR DGGE); Pyrosequencing

Indexed keywords

CHINESE DRUG; FATTY ACID; QUSHI HUAYU FANG; RNA 16S; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHINESE HERB; CLINICAL PRACTICE; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; ESCHERICHIA; FATTY LIVER; INTESTINE FLORA; KLEBSIELLA; LIPID DIET; LIVER; NONALCOHOLIC FATTY LIVER; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PYROSEQUENCING; RAT; WEIGHT REDUCTION;

ANIMALS; CLUSTER ANALYSIS; DIET, HIGH-FAT; DISEASE MODELS, ANIMAL; DRUGS, CHINESE HERBAL; FATTY LIVER; GASTROINTESTINAL TRACT; GENES, BACTERIAL; MALE; METAGENOME; RATS; RNA, RIBOSOMAL, 16S; WEIGHT LOSS;

BACTERIA (MICROORGANISMS); COLLINSELLA; RATTUS; SHIGELLA;

EID: 84876323190     PISSN: 07232020     EISSN: 16180984     Source Type: Journal    
DOI: 10.1016/j.syapm.2012.12.009     Document Type: Article

References (50)

1. Abu-Shanab A., Quigley E.M. The role of the gut microbiota in nonalcoholic fatty liver disease. Nat. Rev. Gastroenterol. Hepatol. 2010, 7:691-701.
2. Amann R.I., Ludwig W., Schleifer K.H. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 1995, 59:143-169.
3. Baker S.S., Baker R.D., Liu W., Nowak N.J., Zhu L. Role of alcohol metabolism in non-alcoholic steatohepatitis. PLoS ONE 2010, 5:e9570.
4. Bergheim I., Weber S., Vos M., Kramer S., Volynets V., Kaserouni S., McClain C.J., Bischoff S.C. Antibiotics protect against fructose-induced hepatic lipid accumulation in mice: role of endotoxin. J. Hepatol. 2008, 48:983-992.
5. Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., Waget A., Delmee E., Cousin B., Sulpice T., Chamontin B., Ferrieres J., Tanti J.F., Gibson G.R., Casteilla L., Delzenne N.M., Alessi M.C., Burcelin R. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007, 56:1761-1772.
6. Chan K. Progress in traditional Chinese medicine. Trends Pharmacol. Sci. 1995, 16:182-187.
7. Cole J.R., Wang Q., Cardenas E., Fish J., Chai B., Farris R.J., Kulam-Syed-Mohideen A.S., McGarrell D.M., Marsh T., Garrity G.M., Tiedje J.M. The Ribosomal Database Project: improved alignments and new tools for rRNA analysis. Nucleic Acids Res. 2009, 37:D141-D145.
8. Crow J.M. Microbiome: that healthy gut feeling. Nature 2011, 480:S88-S89.
9. Deng Z.Y., Zhang J.W., Li J., Fan Y.W., Cao S.W., Huang R.L., Yin Y.L., Zhong H.Y., Li T.J. Effect of polysaccharides of cassiae seeds on the intestinal microflora of piglets. Asia Pac. J. Clin. Nutr. 2007, 16(Suppl. 1):143-147.
10. DeSantis T.Z., Hugenholtz P., Keller K., Brodie E.L., Larsen N., Piceno Y.M., Phan R., Andersen G.L. NAST: a multiple sequence alignment server for comparative analysis of 16S rRNA genes. Nucleic Acids Res. 2006, 34:W394-W399.
11. Dumas M.E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V., Lindon J.C., Mitchell S.C., Holmes E., McCarthy M.I., Scott J., Gauguier D., Nicholson J.K. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. U.S.A. 2006, 103:12511-12516.
12. Gordon J.I., Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:15718-15723.
13. Haukeland J.W., Damas J.K., Konopski Z., Loberg E.M., Haaland T., Goverud I., Torjesen P.A., Birkeland K., Bjoro K., Aukrust P. Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCl2. J. Hepatol. 2006, 44:1167-1174.
14. Jia W., Li H.K., Zhao L.P., Nicholson J.K. Gut microbiota: a potential new territory for drug targeting. Nat. Rev. Drug Discov. 2008, 7:123-129.
15. Kageyama A., Benno Y., Nakase T. Phylogenetic and phenotypic evidence for the transfer of Eubacterium aerofaciens to the genus Collinsella as Collinsella aerofaciens gen. nov., comb. nov. Int. J. Syst. Bacteriol. 1999, 49:557-565.
16. Kassinen A., Krogius-Kurikka L., Makivuokko H., Rinttila T., Paulin L., Corander J., Malinen E., Apajalahti J., Palva A. The fecal microbiota of irritable bowel syndrome patients differs significantly from that of healthy subjects. Gastroenterology 2007, 133:24-33.
17. Kato M., Ishige A., Anjiki N., Yamamoto M., Irie Y., Taniyama M., Kibe R., Oka J., Benno Y., Watanabe K. Effect of herbal medicine Juzentaihoto on hepatic and intestinal heat shock gene expression requires intestinal microflora in mouse. World J. Gastroenterol. 2007, 13:2289-2297.
18. Knight R., Lozupone C., Hamady M. UniFrac - an online tool for comparing microbial community diversity in a phylogenetic context. BMC Bioinform. 2006, 7:371.
19. Kok N., Roberfroid M., Delzenne N. Dietary oligofructose modifies the impact of fructose on hepatic triacylglycerol metabolism. Metabolism. 1996, 45:1547-1550.
20. Li H.S., Feng Q., Hu Y.Y., Chen S.D., Li X.M., Peng J.H., Xu L.L., Liu C. Effect of Qushi Huayu Decoction on high-fat diet induced hepatic lipid deposition in rats. Chin. J. Integr. Tradit. West. Med. 2009, 29:1092-1095.
21. Li W., Godzik A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006, 22:1658-1659.
22. Li Z., Yang S., Lin H., Huang J., Watkins P.A., Moser A.B., Desimone C., Song X.Y., Diehl A.M. Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease. Hepatology 2003, 37:343-350.
23. Loguercio C., Federico A., Tuccillo C., Terracciano F., D'Auria M.V., De Simone C., Del Vecchio Blanco C. Beneficial effects of a probiotic VSL#3 on parameters of liver dysfunction in chronic liver diseases. J. Clin. Gastroenterol. 2005, 39:540-543.
24. Ludwig W., Strunk O., Westram R., Richter L., Meier H., Yadhukumar, Buchner A., Lai T., Steppi S., Jobb G., Forster W., Brettske I., Gerber S., Ginhart A.W., Gross O., Grumann S., Hermann S., Jost R., Konig A., Liss T., Lussmann R., May M., Nonhoff B., Reichel B., Strehlow R., Stamatakis A., Stuckmann N., Vilbig A., Lenke M., Ludwig T., Bode A., Schleifer K.H. ARB: a software environment for sequence data. Nucleic Acids Res. 2004, 32:1363-1371.
25. Makivuokko H., Tiihonen K., Tynkkynen S., Paulin L., Rautonen N. The effect of age and non-steroidal anti-inflammatory drugs on human intestinal microbiota composition. Br. J. Nutr. 2010, 103:227-234.
26. Malinen E., Krogius-Kurikka L., Lyra A., Nikkila J., Jaaskelainen A., Rinttila T., Vilpponen-Salmela T., von Wright A.J., Palva A. Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome. World J. Gastroenterol. 2010, 16:4532-4540.
27. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda N., Rizzetto M. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003, 37:917-923.
28. Marchesini G., Moscatiello S., Agostini F., Villanova N., Festi D. Treatment of non-alcoholic fatty liver disease with focus on emerging drugs. Expert. Opin. Emerg. Drugs 2011, 16:121-136.
29. Moore W., Moore L. Intestinal floras of populations that have a high risk of colon cancer. Appl. Environ. Microbiol. 1995, 61:3202-3207.
30. Muyzer G., de Waal E.C., Uitterlinden A.G. Profiling of complex microbial populations by denaturing gradient gel electrophoresis analysis of polymerase chain reaction-amplified genes coding for 16S rRNA. Appl. Environ. Microbiol. 1993, 59:695-700.
31. Neal M.D., Leaphart C., Levy R., Prince J., Billiar T.R., Watkins S., Li J., Cetin S., Ford H., Schreiber A., Hackam D.J. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J. Immunol. 2006, 176:3070-3079.
32. Normile D. The new face of traditional Chinese medicine. Science 2003, 299:188-190.
33. Osten D.W. Selection of optimal regression models via cross-validation. J. Chemom. 1988, 2:39-48.
34. Qin J., Li Y., Cai Z., Li S., Zhu J., Zhang F., Liang S., Zhang W., Guan Y., Shen D. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490:55-60.
35. Ruiz A.G., Casafont F., Crespo J., Cayon A., Mayorga M., Estebanez A., Fernadez-Escalante J.C., Pons-Romero F. Lipopolysaccharide-binding protein plasma levels and liver TNF-alpha gene expression in obese patients: evidence for the potential role of endotoxin in the pathogenesis of non-alcoholic steatohepatitis. Obes. Surg. 2007, 17:1374-1380.
36. Sakata T. Stimulatory effect of short-chain fatty acids on epithelial cell proliferation in the rat intestine: a possible explanation for trophic effects of fermentable fibre, gut microbes and luminal trophic factors. Br. J. Nutr. 1987, 58:95-103.
37. Scheppach W., Bartram P., Richter A., Richter F., Liepold H., Dusel G., Hofstetter G., Rüthlein J., Kasper H. Effect of short-chain fatty acids on the human colonic mucosa in vitro. J. Parenter. Enteral. Nutr. 1992, 16:43-48.
38. Schloss P.D., Handelsman J. Introducing DOTUR, a computer program for defining operational taxonomic units and estimating species richness. Appl. Environ. Microbiol. 2005, 71:1501-1506.
39. Steffen E.K., Berg R.D., Deitch E.A. Comparison of translocation rates of various indigenous bacteria from the gastrointestinal tract to the mesenteric lymph node. J. Infect. Dis. 1988, 157:1032-1038.
40. Tannock G.W., Munro K., Bibiloni R., Simon M.A., Hargreaves P., Gopal P., Harmsen H., Welling G. Impact of consumption of oligosaccharide-containing biscuits on the fecal microbiota of humans. Appl. Environ. Microbiol. 2004, 70:2129-2136.
41. Wang T., Cai G., Qiu Y., Fei N., Zhang M., Pang X., Jia W., Cai S., Zhao L. Structural segregation of gut microbiota between colorectal cancer patients and healthy volunteers. ISME J. 2011, 6:320-329.
42. Wang Y., Xu N., Xi A., Ahmed Z., Zhang B., Bai X. Effects of Lactobacillus plantarum MA2 isolated from Tibet kefir on lipid metabolism and intestinal microflora of rats fed on high-cholesterol diet. Appl. Microbiol. Biotechnol. 2009, 84:341-347.
43. Westad F., Martens H. Variable selection in near infrared spectroscopy based on significance testing in partial least squares regression. J. Near Infrared Spectrosc. 2000, 8:117-124.
44. Wigg A.J., Roberts-Thomson I.C., Dymock R.B., McCarthy P.J., Grose R.H., Cummins A.G. The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis. Gut 2001, 48:206-211.
45. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
46. Zhang C.H., Zhang M.H., Wang S.Y., Han R.J., Cao Y.F., Hua W.Y., Mao Y.J., Zhang X.J., Pang X.Y., Wei C.C., Zhao G.P., Chen Y., Zhao L.P. Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice. ISME J. 2010, 4:312-313.
47. Zhang X., Zhao Y., Zhang M., Pang X., Xu J., Kang C., Li M., Zhang C., Zhang Z., Zhang Y., Li X., Ning G., Zhao L. Structural changes of gut microbiota during berberine-mediated prevention of obesity and insulin resistance in high-fat diet-fed rats. PLoS ONE 2012, 7:e42529.
48. Zhang X., Zhao Y.F., Hu Y.Y., Liu P., Zhao L.P. Whole-body systems biology based on functional metagenomics - new opportunity for the modernization of Traditional Chinese Medicine. Modern. Tradit. Chin. Med. Mater. Med./World Sci. Technol. 2011, 13:202-212.
49. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109.
50. Zoetendal E.G., von Wright A., Vilpponen-Salmela T., Ben-Amor K., Akkermans A.D., de Vos W.M. Mucosa-associated bacteria in the human gastrointestinal tract are uniformly distributed along the colon and differ from the community recovered from feces. Appl. Environ. Microbiol. 2002, 68:3401-3407.